Amprius Technologies Stock Rises 1.58% Amid Strong Q4 Results and Analyst Upgrades Ranking 473rd in Daily Trading Activity

Market Snapshot

Amprius Technologies (AMPX) closed 1.58% higher on March 10, 2026, outperforming broader market trends. The stock saw a trading volume of $0.26 billion, ranking 473rd in daily trading activity. Despite the modest gain, the move reflects renewed investor interest following recent earnings and guidance updates. The company’s shares traded at a market capitalization of approximately $2.14 billion, with a 52-week range of $1.70 to $17.74.

Key Drivers

Amprius Technologies’ stock rally was primarily fueled by its Q4 2025 financial results, which exceeded expectations. The firm reported revenue of $25.23 million, a 137% year-over-year increase, and posted its first positive adjusted EBITDA. While the company still reported a net loss of $44 million for the quarter, the loss narrowed significantly compared to $9.6 million in the prior-year period. Analysts highlighted these improvements as evidence of operational progress, with HC Wainwright projecting a path to breakeven EBITDA by 2027. The results, coupled with 2026 guidance targeting at least $125 million in revenue, positioned AmpriusAMPX+1.58% as a high-growth play in the battery sector.

Analyst sentiment further amplified the stock’s momentum. Eight analysts upgraded their ratings to “Buy” in the past month, with consensus price targets averaging $18.38. Notably, B. Riley Financial raised its target to $22, while Roth MKM and Craig-Hallum increased theirs to $20 and $21, respectively. These upgrades were driven by Amprius’ technological edge in silicon-anode battery development, which offers higher energy density than conventional lithium-ion alternatives. Northland Securities revised its Q4 2026 EPS estimate from -$0.01 to $0.01, signaling confidence in the company’s ability to turn earnings positive. However, Weiss Ratings maintained a “Sell (e+)” rating, underscoring concerns about GAAP profitability and execution risks.

A strategic partnership with Nanotech Energy to expand U.S. battery production also contributed to the stock’s rise. This collaboration aims to scale manufacturing of high-performance silicon battery cells, targeting aerospace, defense, and commercial applications. The move aligns with Amprius’ broader strategy to capitalize on the global shift toward energy-dense storage solutions. Additionally, institutional investors increased their stakes, with Vanguard Group and Geode Capital Management boosting holdings by 9.5% and 10.5%, respectively, in Q4 2025.

Despite these positives, insider selling raised caution. CTO Constantin Ionel Stefan and Director Kang Sun sold 492,827 and 950,548 shares, respectively, in early 2026, representing significant reductions in their ownership. The transactions, totaling $26.4 million, were disclosed as non-recurring and unrelated to operational performance. However, the sales highlighted potential short-term profit-taking and reduced insider confidence in the stock’s near-term trajectory.

The stock’s volatility is further compounded by its high beta of 3.04 and unprofitable GAAP results. While adjusted EBITDA turned positive, the company’s full-year 2026 guidance still projects a net loss of -$0.45 per share. This divergence between non-GAAP metrics and GAAP performance creates uncertainty for investors, particularly if revenue growth stalls or capital expenditures exceed expectations. Analysts remain divided on the valuation, with some arguing the rally has priced in much of the upside, while others view the current price as a discount to long-term potential.

In summary, Amprius’ stock performance reflects a mix of optimism and caution. Strong revenue growth, analyst upgrades, and strategic partnerships are driving bullish sentiment, but insider sales and GAAP profitability challenges temper the outlook. The coming quarters will be critical in determining whether the company can sustain its momentum or face a correction if execution falters.